Abiraterone acetate: a potential source of interference in testosterone assays.
Prostate cancer is the second most common cause of cancer in the UK with one in eight men diagnosed during their lifetime. Prostate cancer is typically dependent on androgens for growth, survival and metastasis. Androgen deprivation therapy targets this dependency through drugs such as luteinizing h...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
De Gruyter
2018
|